HIGHLIGHTS
- who: Long Chen et al. from the Tianjin Medical University General Hospital, China have published the research: Functional characterization of TSPAN7 as a novel indicator for immunotherapy in glioma, in the Journal: (JOURNAL)
- what: As IDH mutation and 1p/19q deletion status are the dominant molecular marker for glioma patients, the authors investigate the relationship between them and TSPAN7 expression in TCGA and CGGA.
- how: The results were analyzed with FlowJo10.4 software. was found that the expression level of TSPAN7 was higher in the MGMT methylation subgroup compared with MGMT nonmethylation subgroup . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.